- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Trastuzumab deruxtecan
Total 1194 results
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastItaly, Germany, Poland
-
Japan Breast Cancer Research GroupEisai Co., Ltd.Recruiting
-
Eli Lilly and CompanyCompletedBreast Cancer | Breast Neoplasms | Cancer of the BreastUnited States
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingColorectal NeoplasmsUnited States, Canada, Italy, Argentina, United Kingdom, China, Japan, Belgium, France, Korea, Republic of, Spain, Taiwan, Brazil, Ireland, Netherlands, Australia, Slovakia, Chile, Poland, Norway, Switzerland, Austria, Germany, Portugal, Gree... and more
-
The Greater Poland Cancer CentreActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Dana-Farber Cancer InstituteCompleted
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Advanced Breast Cancer
-
Shanghai Institute Of Biological ProductsFudan UniversityCompletedHER2-positive Early Breast CancerChina
-
City of Hope Medical CenterGlaxoSmithKline; NovartisActive, not recruitingBreast Neoplasms | HER2/Neu Positive | Geriatric Health ServicesUnited States
-
University of WashingtonBristol-Myers Squibb; GlaxoSmithKline; AmgenTerminatedBreast CancerUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States
-
Hoffmann-La RocheChugai PharmaceuticalCompletedGastric CancerBelgium, France, Italy, Spain, China, Costa Rica, Denmark, Germany, Portugal, Taiwan, United Kingdom, Russian Federation, Korea, Republic of, Peru, Turkey, Mexico, Australia, Brazil, Finland, Guatemala, India, Japan, Panama, South Africa
-
Novartis PharmaceuticalsBreast International Group; SOLTI Breast Cancer Research GroupCompletedNeoplasms, BreastFrance, Spain, United Kingdom, Belgium, Argentina, Czechia, Germany, Italy, Norway, Russian Federation, Sweden, Taiwan, Hong Kong, Brazil, Hungary, India, Korea, Republic of, Pakistan, Peru, Romania, South Africa, Ukraine, Canada, Lit...
-
George E. PeoplesGenentech, Inc.; Sellas Life Sciences GroupCompleted
-
NovoCure GmbHZai Lab (Shanghai) Co., Ltd.UnknownGastric Cancer | GastroEsophageal CancerHong Kong
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompletedHER2-Positive Early Stage Breast CancerUnited States
-
iOMEDICO AGAmgen; Arbeitsgemeinschaft fur Internistische OnkologieWithdrawnAdvanced Breast Cancer | HER2-positive Breast CancerGermany
-
Spanish Breast Cancer Research GroupSeagen Inc.RecruitingHER2-positive Metastatic Breast Cancer | Locally Advanced HER2 Positive Breast CarcinomaSpain
-
Breast Cancer Trials, Australia and New ZealandRecruitingBreast Cancer | HER2-positive Breast CancerAustralia
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, China, United States, Australia, Hong Kong, Malaysia, Korea, Republic of, Singapore, Belgium, Japan, India, France, Hungary, Romania, Italy, Bulgaria, Germany, Serbia, United Kingdom, South Africa, Canada, Israel, Taiwan, Switz... and more
-
Bristol-Myers SquibbCompleted
-
SCRI Development Innovations, LLCEli Lilly and Company; Genentech, Inc.CompletedBreast CancerUnited States
-
Royal Marsden NHS Foundation TrustEli Lilly and Company; AstraZeneca; Clovis Oncology, Inc.; MedImmune LLCRecruitingAdenocarcinoma of the Stomach | Adenocarcinoma of the Oesophagus | Adenocarcinoma of the Gastro-oesophageal JunctionUnited Kingdom
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLC; Breast Cancer Research FoundationActive, not recruitingBreast Cancer | HER2-positive Breast CancerUnited States
-
Spanish Breast Cancer Research GroupBristol-Myers SquibbCompletedMetastatic Breast CancerSpain
-
Milton S. Hershey Medical CenterTerminatedChronic Myeloid Leukemia, Chronic PhaseUnited States
-
Alliance Foundation Trials, LLC.Eli Lilly and Company; Pfizer; Genentech, Inc.; Foundation MedicineRecruitingEndometrial CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Breast Cancer | Invasive Carcinoma of the Breast | Node Negative Breast Cancer | Micrometastasis Breast CancerUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)WithdrawnBreast Cancer | Brain and Central Nervous System Tumors | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its Treatment | Drug/Agent Toxicity by Tissue/Organ
-
Fudan UniversityNot yet recruiting
-
Hoffmann-La RocheCompleted
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerBelgium, France, Netherlands, United States, Spain
-
SCRI Development Innovations, LLCEli Lilly and Company; Genentech, Inc.Completed
-
M.D. Anderson Cancer CenterNovartisCompletedBreast Cancer | Neoplasm MetastasisUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerChina, United States, France, Italy, United Kingdom, Taiwan, Turkey, Egypt, Germany, Hong Kong, Belgium, Canada, Russian Federation, Lebanon, Japan, Australia, Greece, Korea, Republic of, Ireland, Peru, Argentina, Brazil, Colombia, South... and more
-
Eric Winer, MDMassachusetts General Hospital; Yale University; Dana-Farber Cancer Institute; Beth... and other collaboratorsCompletedBreast CancerUnited States
-
Shengjing HospitalRecruitingStage II-III Breast CancerChina
-
H. Lee Moffitt Cancer Center and Research InstituteImmunoRestorationRecruitingHER2-positive Breast CancerUnited States
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein OverexpressionSpain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
-
Sheba Medical CenterCompletedADHD Predominantly Inattentive Type | Attention Deficit/Hyperactivity Disorder Combined Type | ADHD Predominantly Hyperactivity Type | ADHD-not Other SpecifiedIsrael
-
Hoffmann-La RocheCompletedBreast CancerItaly, Spain, China, Taiwan, Russian Federation, Canada, Germany, Austria, Hungary, Belgium, Australia, Brazil, Mexico, Poland, Panama
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
UNC Lineberger Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedHER-2 Positive Breast CancerUnited States
-
Duke UniversityGenentech, Inc.; Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
SanofiCompleted
-
Gustave Roussy, Cancer Campus, Grand ParisHoffmann-La RocheRecruiting
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer InvasiveChina